2024-02-19
Researchers have developed drug-loaded nanoparticles that selectively target the cells responsible for causing damaging inflammation following a spinal cord injury. Given to mice soon after an injury, the novel therapy reduced inflammation and improved motor function, opening the door to new therapeutic possibilities for people with spinal injuries.
